The FDA Regulatory Landscape For AI In Medical Devices
The FDA Regulatory Landscape For AI In Medical Devices unknown
By Michele Buenafe, Jake Harper, and Andrew Gray
In recent
FDA Updates for Week of Feb. 27, 2023
FDA Updates for Week of Feb. 27, 2023 unknown
FDA approves Kevzara for inflammatory rheumatic disease.
The FDA has approved
FDA Updates for Week of Feb. 20, 2023
FDA Updates for Week of Feb. 20, 2023 unknown
FDA approves weekly hemophilia A therapy.
The FDA has approved Altuviiio
Mindmaze launches a first-of-a-kind medical device for hand therapy solution
Mindmaze launches a first-of-a-kind medical device for hand therapy solution unknown
MindMaze, a global pioneer in AI-driven digital neurotherapeutics, has
FDA Updates for the Week of Jan 30, 2023
FDA Updates for the Week of Jan 30, 2023 unknown
FDA approves Trodelvy for HR+/HER2- breast cancer.
The FDA
FDA approves AI ultrasound application for musculoskeletal imaging
FDA approves AI ultrasound application for musculoskeletal imaging Andrea Fox
Clarius Mobile Health, which first introduced wireless handheld imaging for
FDA Updates for the Week of Jan. 23, 2023
FDA approves Lilly’s BTK inhibitor for rare blood cancer.
The FDA has granted accelerated approval to Lilly’s Jaypirca
FDA Updates for the Week of Jan. 16, 2023
FDA Updates for the Week of Jan. 16, 2023 unknown
FDA approves Brukinsa for chronic lymphocytic leukemia.
he FDA has
FDA Updates for the Week of Jan. 9, 2023
FDA Updates for the Week of Jan. 9, 2023 unknown
FDA approves Rybelsus for first-line treatment of diabetes.
The FDA
Vorschlag der EU-Kommission: Mehr Zeit für MDR-Umsetzung
9. Januar 2023, 11:23 Uhr | Ute Häußler
Um das Risiko von Engpässen zu vermeiden, hat die EU-Kommission jetzt einen